Module

Overcoming Barriers to Treatment Success in HCV Therapy

Source: Advanced Topics in Hepatitis C Management: Tools for Nurse Practitioners and Physician Assistants

Overcoming Barriers to Treatment Success in HCV Therapy

CME Program Director: Michael W. Fried, MD

Faculty:

Ruth J. Corbett, MSN, ARNP, CCRC

CME CREDIT INFORMATION

Release Date: 06/02/07

Expiration Date: 06/01/08

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.1 Nursing CE credits

Physician Assistants: maximum of 1.0 hour of AAPA Category I (Preapproved) credit

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Summarize the key obstacles for treatment success in patients initiating HCV therapy including substance abuse, psychiatric disorders, insulin resistance, and fatty liver disease
Discuss strategies for assessing and screening patients for treatment barriers prior to initiating HCV therapy
Describe the pretreatment and on-treatment management of barriers to HCV therapy

Topics covered include:

Introduction
Barriers to Treatment and Management Strategies
Managing Comorbidities During HCV Therapy
Management of Psychiatric Disorders
Management of Substance Abuse Patients
Management of Insulin Resistance, Obesity, and Nonalcoholic Fatty Liver Disease
Summary

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.